By 1996, newtechnologybrought new opportunity. Scientists with the companyAffymetrixinSantaClara, Calif. developed the first mitochondrialsequencingmicroarray.
With the case of Illumina, while Jay Flatley is without question an outstanding CEO, much credit is also due to the revolutionary microarray-technology that enabled Illumina to grow on the turf of Affymetrix.